首页 | 本学科首页   官方微博 | 高级检索  
检索        

噻吩诺啡及其活性代谢产物的药代动力学研究
引用本文:孔琦,王晓英,李敬来,乔建忠,袁淑兰,张振清,宫泽辉,阮金秀.噻吩诺啡及其活性代谢产物的药代动力学研究[J].解放军药学学报,2012,28(1):20-23,28.
作者姓名:孔琦  王晓英  李敬来  乔建忠  袁淑兰  张振清  宫泽辉  阮金秀
作者单位:军事医学科学院毒物药物研究所,北京,100850
基金项目:国家科学自然基金项目资助 No.30472059
摘    要:目的建立灵敏、专一的可同时测定比格犬血浆中噻吩诺啡及其代谢产物葡萄糖醛酸结合物含量的方法。方法采用HPLC-MS/MS法测定比格犬血中原型和代谢产物的浓度,分析在比格犬中的药代动力学参数。结果噻吩诺啡和代谢产物线性范围分别为0.02~50 ng/ml和0.2~500 ng/ml,定量下限分别为0.02 ng/ml和0.2 ng/ml,日内和日间精密度均小于9%,回收率均大于60%,在样品贮存、处理和分析过程中稳定性良好。比格犬单次口服噻吩诺啡0.2、0.6、1.8 mg/kg后,原型的Cmax分别为1.42、2.08、4.82 ng/ml,AUC分别为8.60、13.24和26.10μg.h/L,Tmax约为0.55~0.65 h,t1/2为10~13 h,MRT约为10~12 h;其代谢产物(噻吩诺啡葡萄糖醛酸结合物)的Cmax分别为1.78、5.03、7.09μg/L,AUC分别为9.37、22.34、41.40μg.h/L,Tmax为0.47~1.1 h,t1/2为18~40 h,MRT在11~17 h。比格犬口服0.2 mg/kg噻吩诺啡生物利用度为12.65%。结论本研究首次报道了噻吩诺啡及其葡萄糖醛酸结合物在比格犬中药代动力学研究,证明药物在犬体内的吸收和转化较快,单次口服盐酸噻吩诺啡低、中、高3种剂量后原型及其葡萄糖醛酸结合物药代动力学过程均符合一级吸收二房室模型。

关 键 词:噻吩诺啡  噻吩诺啡葡萄糖醛酸结合物  HPLC-MS/MS  药代动力学

Simultaneous Determination of Thienorphine and Its Active Metabolite Thienorphine-glucuronide by HPLC-MS/MS and Application to Pharmacokinetic Studies
KONG Qi , WANG Xiao-ying , LI Jing-lai , QIAO Jian-zhong , YUAN Shu-lan , ZHANG Zhen-qing , GONG Ze-hui , RUAN Jin-xiu.Simultaneous Determination of Thienorphine and Its Active Metabolite Thienorphine-glucuronide by HPLC-MS/MS and Application to Pharmacokinetic Studies[J].Pharmaceutical Journal of Chinese People's Liberation Army,2012,28(1):20-23,28.
Authors:KONG Qi  WANG Xiao-ying  LI Jing-lai  QIAO Jian-zhong  YUAN Shu-lan  ZHANG Zhen-qing  GONG Ze-hui  RUAN Jin-xiu
Institution:Instistute of Pharmacology and Toxicology,Academy of Military Medical Sciences,Beijing 100850,China
Abstract:Objective To develop a simple,sensitive and rapid method for the simultaneous quantification of thienorphine and thienorphine glucuronide conjugate in dog plasma.Methods HPLC-MS/MS method was established to determine the concentration of thienorphine and its metabolite in dog plasma.Results There was a linear calibration curve over the concentration range of 0.02-50 ng/ml for thienorphine and 0.2-500 ng/ml for thienorphine glucuronide conjugate,respectively.LOQ of thienorphine and thienorphine glucuronide conjugate was 0.02 and 0.2 ng/ml,respectively.The intra-and inter-batch precision was less than 9% and their recovery exceeded 60%.The concentration-time profiles of thienorphine and thienorphine glucuronide in blood were analyzed following a single oral administration of 0.2,0.6,1.8 mg/kg thienorphine to dogs.The average peak concentration for thienorphine was 1.42,2.08,4.82 ng/ml,respectively and the mean AUC was 8.60,13.24,26.10 μg·h/L,respectively.The value of Tmax,t1/2 and MRT time for thienorphine was ranged from 0.55 to 0.65 h,from 10 to 13 h,from 10 to 12 h,respectively.The average peak concentration for thienorphine glucuronide was 1.78,5.03,7.09 ng/ml,and the mean AUC was 9.37,22.34,41.40 μg · h/L,respectively.The value of Tmax,t1/2 and MRT for thienorphine glucuronide ranged from 0.47 to 1.1 h,from 18 to 40 h,from 11 to 17 h.The absolute bioavailability of 0.2 mg/kg thienorphine orally administered to dogs was about 12.65%.Conclusion The concentration-time profiles of thienorphine and thienorphine glucuronide in blood follow an open two-compartment model with firstorder absorption following a single oral administration of 0.2,0.6,1.8 mg / kg thienorphine to dogs.Thienorphine is quickly absorbed and biotransformated into thienorphine glucuronide conjugate.
Keywords:thienorphine  thienorphine glucuronide conjugate  HPLC-MS/MS  pharmacokinetics
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号